112 related articles for article (PubMed ID: 35007521)
1. Glutamic oxaloacetic transaminase 1 as a potential target in human cancer.
Song Z; Yang Y; Wu Y; Zheng M; Sun D; Li H; Chen L
Eur J Pharmacol; 2022 Feb; 917():174754. PubMed ID: 35007521
[TBL] [Abstract][Full Text] [Related]
2. Adapalene inhibits ovarian cancer ES-2 cells growth by targeting glutamic-oxaloacetic transaminase 1.
Wang Q; Zhang Q; Luan S; Yang K; Zheng M; Li K; Chen L; Li H
Bioorg Chem; 2019 Dec; 93():103315. PubMed ID: 31605927
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutamate oxaloacetate transaminase 1 in cancer cell lines results in altered metabolism with increased dependency of glucose.
Zhou X; Curbo S; Li F; Krishnan S; Karlsson A
BMC Cancer; 2018 May; 18(1):559. PubMed ID: 29751795
[TBL] [Abstract][Full Text] [Related]
4. Discovery of GOT1 Inhibitors from a Marine-Derived
Yan S; Qi C; Song W; Xu Q; Gu L; Sun W; Zhang Y
Mar Drugs; 2021 Oct; 19(11):. PubMed ID: 34822459
[TBL] [Abstract][Full Text] [Related]
5. A covalent small molecule inhibitor of glutamate-oxaloacetate transaminase 1 impairs pancreatic cancer growth.
Yoshida T; Yamasaki S; Kaneko O; Taoka N; Tomimoto Y; Namatame I; Yahata T; Kuromitsu S; Cantley LC; Lyssiotis CA
Biochem Biophys Res Commun; 2020 Feb; 522(3):633-638. PubMed ID: 31787239
[TBL] [Abstract][Full Text] [Related]
6. Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors.
Holt MC; Assar Z; Beheshti Zavareh R; Lin L; Anglin J; Mashadova O; Haldar D; Mullarky E; Kremer DM; Cantley LC; Kimmelman AC; Stein AJ; Lairson LL; Lyssiotis CA
Biochemistry; 2018 Nov; 57(47):6604-6614. PubMed ID: 30365304
[TBL] [Abstract][Full Text] [Related]
7. The discovery of a non-competitive GOT1 inhibitor, hydralazine hydrochloride, via a coupling reaction-based high-throughput screening assay.
Wu Q; Sun Z; Chen Z; Liu J; Ding H; Luo C; Wang M; Du D
Bioorg Med Chem Lett; 2022 Oct; 73():128883. PubMed ID: 35820623
[TBL] [Abstract][Full Text] [Related]
8. System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma.
Wang B; Pei J; Xu S; Liu J; Yu J
Comput Biol Med; 2023 Oct; 165():107415. PubMed ID: 37657356
[TBL] [Abstract][Full Text] [Related]
9. Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma.
Anglin J; Zavareh RB; Sander PN; Haldar D; Mullarky E; Cantley LC; Kimmelman AC; Lyssiotis CA; Lairson LL
Bioorg Med Chem Lett; 2018 Sep; 28(16):2675-2678. PubMed ID: 29731362
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification and preliminary crystallographic studies of human glutamate oxaloacetate transaminase 1 (GOT1).
Jiang X; Chang H; Zhou Y
Protein Expr Purif; 2015 Sep; 113():102-6. PubMed ID: 26003525
[TBL] [Abstract][Full Text] [Related]
11. Glutamic-oxaloacetic transaminase 1 regulates adipocyte differentiation by altering nicotinamide adenine dinucleotide phosphate content.
Yang Y; Cheng Z; Zhang W; Hei W; Lu C; Cai C; Zhao Y; Gao P; Guo X; Cao G; Li B
Anim Biosci; 2022 Feb; 35(2):155-165. PubMed ID: 34474530
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.
Yang Y; Zheng M; Han F; Shang L; Li M; Gu X; Li H; Chen L
J Mol Med (Berl); 2022 Apr; 100(4):599-612. PubMed ID: 35212782
[TBL] [Abstract][Full Text] [Related]
13. miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma.
Zhang K; Wu L; Zhang P; Luo M; Du J; Gao T; O'Connell D; Wang G; Wang H; Yang Y
Mol Carcinog; 2018 Nov; 57(11):1566-1576. PubMed ID: 30035324
[TBL] [Abstract][Full Text] [Related]
14. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells.
Abrego J; Gunda V; Vernucci E; Shukla SK; King RJ; Dasgupta A; Goode G; Murthy D; Yu F; Singh PK
Cancer Lett; 2017 Aug; 400():37-46. PubMed ID: 28455244
[TBL] [Abstract][Full Text] [Related]
15. Rod photoreceptor-specific deletion of cytosolic aspartate aminotransferase, GOT1, causes retinal degeneration.
Subramanya S; Goswami MT; Miller N; Weh E; Chaudhury S; Zhang L; Andren A; Hager H; Weh KM; Lyssiotis CA; Besirli CG; Wubben TJ
Front Ophthalmol (Lausanne); 2023; 3():. PubMed ID: 38725581
[TBL] [Abstract][Full Text] [Related]
16. Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer.
Zhou X; Liu K; Cui J; Xiong J; Wu H; Peng T; Guo Y
J Exp Clin Cancer Res; 2021 Apr; 40(1):124. PubMed ID: 33832516
[TBL] [Abstract][Full Text] [Related]
17. c-Myc protects hepatocellular carcinoma cell from ferroptosis induced by glutamine deprivation via upregulating GOT1 and Nrf2.
Zhao Y; Wang Y; Miao Z; Liu Y; Yang Q
Mol Biol Rep; 2023 Aug; 50(8):6627-6641. PubMed ID: 37358765
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional analysis of disease-associated mutations in GOT1 gene: An in silico study.
Saxena S; Achyuth B S; Murthy TPK; Chandramohan V; Yadav AK; Singh TR
Comput Biol Med; 2021 Sep; 136():104695. PubMed ID: 34352456
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage.
Dopico-López A; Pérez-Mato M; da Silva-Candal A; Iglesias-Rey R; Rabinkov A; Bugallo-Casal A; Sobrino T; Mirelman D; Castillo J; Campos F
Transl Res; 2021 Apr; 230():68-81. PubMed ID: 33132087
[TBL] [Abstract][Full Text] [Related]
20. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.
Wang J; Wang B; Ren H; Chen W
Biochem Biophys Res Commun; 2019 Jan; 509(1):241-248. PubMed ID: 30591220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
